Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Recent News

03/29/17Global Blood Therapeutics to Present at the 16th Annual Needham Healthcare Conference
03/13/17Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results
03/01/17Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in March
02/27/17Global Blood Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares

More »

Media Resources

Media Contact

Julie Normart